12.01.2023 21:00:00
|
CVS Health Names Sam Khichi Executive Vice President, Chief Policy Officer and General Counsel
WOONSOCKET, R.I., Jan. 12, 2023 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Sam Khichi will join the company as Executive Vice President, Chief Policy Officer and General Counsel, effective February 13. He will lead the legal, compliance, and government affairs teams who support CVS Health's strategy to make health care more accessible and affordable, leading to better health outcomes for all.
"Sam brings diversified experience to many key issues for CVS Health, including geopolitical matters, data privacy, and compliance," said CVS Health President and CEO Karen S. Lynch. "He has an exceptional track record of managing complex health care business and legal strategies."
Khichi will become a member of the company's executive leadership team and report to Lynch. Prior to joining CVS Health, he served at Becton Dickinson as Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs and General Counsel. He joined Becton Dickinson through the acquisition of C. R. Bard where he served as Senior Vice President, General Counsel and Secretary, and previously was the Chief Administrative Officer, Senior Vice President and General Counsel at Catalent Pharma Solutions. Khichi has led significant transformations at complex and large-scale health care organizations.
"This is an exciting time to join CVS Health and be part of a team whose strategy is redefining how health care is delivered in this country," Khichi said. "I have long admired CVS Health for its innovation and leadership in advancing the consumer health care experience. Achieving transformation of this scale requires changing the way information is shared and technology utilized by consumers, employers, and providers and CVS Health is uniquely positioned to lead this change."
Khichi succeeds Tom Moriarty, who plans to retire in April. Moriarty has played a critical role in many significant CVS Health moments, from the company's industry-leading role during the COVID-19 pandemic to helping lead transformative health care acquisitions.
About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media contact
T.J. Crawford
212-457-0583
CrawfordT2@CVSHealth.com
Investor contact
Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-names-sam-khichi-executive-vice-president-chief-policy-officer-and-general-counsel-301720707.html
SOURCE CVS Health
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
28.01.25 |
Erste Schätzungen: CVS Health stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
24.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
Minuszeichen in New York: S&P 500 präsentiert sich schlussendlich schwächer (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 54,66 | 0,64% |